PSNL
Personalis, Inc.
Services-Medical Laboratories- 売上
- $70m
- 時価総額
- $1.2bn
株価 $11.88 · 100株 1,188円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $73m | $85m | $70m |
| 成長率 | — | 15.1% | ▲17.7% |
| 総利益 | $18m | $27m | $16m |
| 総利益率 | 24.8% | 31.7% | 22.7% |
| 販管費 | $50m | $46m | $54m |
| 販管費率 | 67.7% | 54.6% | 76.9% |
| 営利 | ▲$110m | ▲$68m | ▲$88m |
| 営利率 | ▲149.6% | ▲80.7% | ▲126.4% |
| 純利益 | ▲$108m | ▲$81m | ▲$81m |
| PBR | 9.4 | 6.0 | 4.7 |
| PSR | 16.6 | 14.4 | 17.5 |
| PGPR | 66.9 | 45.4 | 77.2 |
| PER | — | — | — |
| ﾈｯﾄｷｬｯｼｭ | $52m | $86m | $116m |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | ▲66% | ▲144% |
| セールス効率 | — | — | ▲150% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）